Edgestream Partners L.P. Sells 815 Shares of Zoetis Inc. (NYSE:ZTS)

Edgestream Partners L.P. decreased its holdings in Zoetis Inc. (NYSE:ZTS) by 7.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,820 shares of the company’s stock after selling 815 shares during the period. Edgestream Partners L.P.’s holdings in Zoetis were worth $1,600,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Howard Capital Management Group LLC grew its holdings in shares of Zoetis by 0.8% in the third quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company’s stock worth $20,489,000 after acquiring an additional 883 shares during the period. Principal Financial Group Inc. grew its holdings in shares of Zoetis by 17.3% in the third quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company’s stock worth $464,497,000 after acquiring an additional 351,372 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of Zoetis in the third quarter worth $33,000. First Personal Financial Services bought a new stake in shares of Zoetis in the third quarter worth $33,000. Finally, Legacy Capital Wealth Partners LLC grew its holdings in shares of Zoetis by 82.2% in the third quarter. Legacy Capital Wealth Partners LLC now owns 3,211 shares of the company’s stock worth $627,000 after acquiring an additional 1,449 shares during the period. Institutional investors own 92.80% of the company’s stock.

Zoetis Price Performance

Shares of Zoetis stock opened at $171.70 on Tuesday. The stock’s 50-day simple moving average is $166.91 and its 200-day simple moving average is $176.66. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.33. The company has a market capitalization of $76.89 billion, a price-to-earnings ratio of 31.39, a PEG ratio of 2.78 and a beta of 0.94. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The business had revenue of $2.32 billion for the quarter, compared to the consensus estimate of $2.30 billion. As a group, analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. Zoetis’s payout ratio is 36.56%.

Analyst Ratings Changes

ZTS has been the subject of several research analyst reports. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Piper Sandler lifted their target price on Zoetis from $200.00 to $205.00 and gave the company an “overweight” rating in a research report on Thursday, February 27th. Stifel Nicolaus lowered their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Barclays lifted their target price on Zoetis from $242.00 to $244.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Finally, StockNews.com upgraded Zoetis from a “hold” rating to a “buy” rating in a research report on Friday. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $215.90.

Insider Buying and Selling

In related news, EVP Roxanne Lagano sold 326 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total value of $55,804.68. Following the sale, the executive vice president now directly owns 16,107 shares in the company, valued at approximately $2,757,196.26. The trade was a 1.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.16% of the stock is owned by company insiders.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.